Focus on Pharma

3rd edition, September, 25th, 2014, Ramada Plaza Hotel, Europa Hall   The pharmaceutical industry is set to post only a slight growth in Romania, given the reduced availability of medical services for patients and the negative impact of the claw back tax. Producers are also calling for a redesign of the claw-back mechanism, urging that it should take into account only the producer price. The third edition of Focus on Pharma organized by Business Review focuses on the fiscal and legal implications of the current claw back tax for the pharmaceutical industry. Event program: 08.30 – 09.00 Guest registration   09:00 – 12:00 Debate session   Topics:

  • Outlook of the claw back tax
  • Is the claw back still a temporary tax?
  • Industry proposals regarding the computation of the claw back tax
  • Challenges of forecasting the amount in claw back to be paid by producers
  • Claw back related case-law and administrative practices


Invited speakers:

    cristian_busoi-2   Cristian Busoi, European Parliament Member, Committee on Environment, Public Health and Food Safety
dan zaharescu   Dan Zaharescu, Executive Director, APRIM
laurentiu mihai   Laurentiu Mihai, Executive Director, APMGR
Gabor Sztaniszlav_Amgen   Gabor Stanislav, President, LAWG*
Anca grigorescu   Moderator: Anca Grigorescu, Partner, bpv GRIGORESCU STEFANICA


12:00 Lunch & Networking


 IMG_8594 IMG_8539
IMG_8611 IMG_8514
IMG_8584 IMG_8604
 IMG_8606  IMG_8609
 IMG_8610  IMG_8612
 IMG_8614  IMG_8616
 IMG_8617  IMG_8529




Translation provided by:



BR Magazine | Latest Issue

Download PDF: Business Review Magazine June 2024 Issue

The June 2024 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “VTEX secures landmark partnership with major German retailer”. To
Newsroom | 06/06/2024 | 16:28
Advertisement Advertisement
Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue